Physician profile
Eric D Wolfe
NPI 1366606923
$804.60
in general payments reported to CMS, 2019-2025
17 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $29.23 · 2021: $130 · 2022: $181 · 2023: $104 · 2024: $53.17 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $293.72 | 2021-2025 | Belbuca |
| Abbvie INC. | $68.99 | 2023 | Vraylar |
| Merck Sharp & Dohme LLC | $57.40 | 2019-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $44.39 | 2025 | Invega Trinza, Invega Sustenna |
| Lilly USA, LLC | $42.93 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $40.35 | 2024-2025 | Ingrezza |
| Indivior INC. | $37.61 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $34.29 | 2023-2025 | Abilify Asimtufii, Nuedexta |
| Grifols USA, LLC | $33.86 | 2019 | |
| Exact Sciences Corporation | $31.14 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $28.65 | 2025 | Ozempic, Rybelsus |
| Alkermes, INC. | $20.53 | 2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.90 | 2025 | Caplyta |
| Organon LLC | $17.31 | 2022 | |
| Allergan, INC. | $12.22 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.13 | 2020 | |
| Pfizer INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.